+47.6%
GSK vs BBAI
+62.6%
-15.0%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBAI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -3.1% | +3.3% | +0.2% |
| 7D | -3.6% | -4.1% | +0.5% | -3.5% |
| 30D | -5.9% | -12.4% | +6.5% | -5.7% |
| 3M | -4.3% | -29.1% | +24.8% | -3.7% |
| 6M | -10.8% | -32.6% | +21.8% | -10.3% |
| YTD | +1.8% | -47.6% | +49.4% | +2.7% |
| 1Y | +23.5% | -41.0% | +64.5% | +23.6% |
| All | +47.6% | +62.6% | -15.0% | +38.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBAI.
Daily Out/Under-Performance
Portfolio return minus BBAI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBAI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBAI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling